📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

CYP3A4*22 and bleeding risk in ticagrelor users. (2024)

First Author: Asiimwe IG

Attributed to: Multimorbidity Mechanism and Therapeutics Research Collaborative funded by SPF

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bcpt.13977

PubMed Identifier: 38163812

Publication URI: http://europepmc.org/abstract/MED/38163812

Type: Journal Article/Review

Volume: 134

Parent Publication: Basic & clinical pharmacology & toxicology

Issue: 3

ISSN: 1742-7835